The DR4-DQ8 haplotype and a specific T cell receptor Vβ T cell subset are associated with absence of allergy to Can f 1

Clinical and Experimental Allergy

Volumn 35, Issue 6, 2005, Pages 797-803

  Kinnunen, Tuure ^a   Taivainen, A ^b   Partanen, J ^c   Immonen, A ^a   Saarelainen, S ^a   Rytkonen Nissinen M ^a   Rautiainen, J ^a   Virtanen, T ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c FINNISH RED CROSS BLOOD SERVICE   (Finland)

Author keywords

Animal allergy; Can f 1; HLA; T cell receptors; T lymphocytes

Indexed keywords

HLA ANTIGEN CLASS 2; HLA DQ8 ANTIGEN; HLA DR4 ANTIGEN; LIPOCALIN; T LYMPHOCYTE RECEPTOR BETA CHAIN;

ALLERGY; ANIMAL ALLERGY; ARTICLE; CONTROLLED STUDY; DOG; FLOW CYTOMETRY; HAPLOTYPE; HUMAN; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SKIN TEST; T LYMPHOCYTE SUBPOPULATION;

ALLERGENS; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL DIVISION; CELL LINE; DOGS; GENE EXPRESSION REGULATION; HAPLOTYPES; HLA-DQ ANTIGENS; HLA-DR4 ANTIGEN; HUMANS; LEUKOCYTES, MONONUCLEAR; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RECOMBINANT PROTEINS; RESPIRATORY HYPERSENSITIVITY; SKIN TESTS; T-LYMPHOCYTE SUBSETS;

EID: 21844442633     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2005.02247.x     Document Type: Article

References (43)

1. Mäntyjärvi R, Rautiainen J, Virtanen T. Lipocalins as allergens. Biochim Biophys Acta 2000; 1482:308-17.
2. Virtanen T, Zeiler T, Mäntyjärvi R. Important animal allergens are lipocalin proteins: why are they allergenic? Int Arch Allergy Immunol 1999; 120:247-58.
3. Comoy EE, Pestel J, Duez C et al. The house dust mite allergen, Dermatophagoides pteronyssinus, promotes type 2 responses by modulating the balance between IL-4 and IFN-gamma. J Immunol 1998; 160:2456-62.
4. Yusifov TN, Abduragimov AR, Gasymov OK, Glasgow BJ. Endonuclease activity in lipocalins. Biochem J 2000; 347 (Part 3):815-9.
5. Chapman MD, Smith AM, Vailes LD, Arruda LK, Dhanaraj V, Pomes A. Recombinant allergens for diagnosis and therapy of allergic disease. J Allergy Clin Immunol 2000; 106:409-18.
6. Altschul SF, Madden TL, Schaffer AA et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 1997; 25:3389-402.
7. Virtanen T, Zeiler T, Rautiainen J, Mäntyjärvi R. Allergy to lipocalins: a consequence of misguided T-cell recognition of self and nonself. Immunol Today 1999; 20:398-400.
8. Casolaro V, Georas SN, Song Z, Ono SJ. Biology and genetics of atopic disease. Curr Opin Immunol 1996; 8:796-803.
9. King CL, Stupi RJ, Craighead N, June CH, Thyphronitis G. CD28 activation promotes Th2 subset differentiation by human CD4+ cells. Eur J Immunol 1995; 25:587-95.
10. Maggi E, Parronchi P, Manetti R et al. Reciprocal regulatory effects of IFN-gamma and IL-4 on the in vitro development of human Th1 and Th2 clones. J Immunol 1992; 148:2142-7.
11. Hosken NA, Shibuya K, Heath AW, Murphy KM, O'Garra A. The effect of antigen dose on CD4+T helper cell phenotype development in a T cell receptor-alpha beta-transgenic model. J Exp Med 1995; 182:1579-84.
12. Pfeiffer C, Stein J, Southwood S, Ketelaar H, Sette A, Bottomly K. Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo. J Exp Med 1995; 181:1569-74.
13. Murray JS. How the MHC selects Th1/Th2 immunity. Immunol Today 1998; 19:157-63.
14. Brogdon JL, Leitenberg D, Bottomly K. The potency of TCR signaling differentially regulates NFATc/p activity and early IL-4 transcription in naive CD4+ T cells. J Immunol 2002; 168:3825-32.
15. Huang SK, Yi M, Palmer E, Marsh DG. A dominant T cell receptor beta-chain in response to a short ragweed allergen, Amb a 5. J Immunol 1995; 154:6157-62.
16. Liebers V, Raulf-Heimsoth M, Krekel C, Baur X. Flow-cytometric analysis of T-cell receptor expression in peripheral blood lympho-cytes. Int Arch Allergy Immunol 1997; 112:133-9.
17. Beyer K, Hausler T, Kircher M, Nickel R, Wahn U, Renz H. Specific V beta T cell subsets are associated with cat and birch pollen allergy in humans. J Immunol 1999; 162:1186-91.
18. Bakakos P, Smith JL, Warner JO et al. Modification of T-cell receptor Vbeta repertoire in response to allergen stimulation in peanut allergy. J Allergy Clin Immunol 2001; 107:1089-94.
19. Kircher MF, Haeusler T, Nickel R, Lamb JR, Renz H, Beyer K. Vbeta 18.1(+) and V(alpha)2.3(+) T-cell subsets are associated with house dust mite allergy in human subjects. J Allergy Clin Immunol 2002; 109:517-23.
20. Saarelainen S, Taivainen A, Rytkönen-Nissinen M et al. Assessment of recombinant dog allergens Can f 1 and Can f 2 for the diagnosis of dog allergy. Clin Exp Allergy 2004; 34:1576-82.
21. Rautiainen J, Auriola S, Rouvinen J et al. Molecular and crystal properties of Bos d 2, an allergenic protein of the lipocalin family. Biochem Biophys Res Commun 1998; 247:746-50.
22. Oksenberg JR, Panzara MA, Begovich AB et al. Selection for T-cell receptor V beta-D beta-J beta gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis. Nature 1993; 362:68-70.
23. Musette P, Bequet D, Delarbre C, Gachelin G, Kourilsky P, Dormont D. Expansion of a recurrent V beta 5.3+ T-cell population in newly diagnosed and untreated HLA-DR2 multiple sclerosis patients. Proc Natl Acad Sci USA 1996; 93:12461-6.
24. Platts-Mills T, Vaughan J, Squillace S, Woodfolk J, Sporik R. Sensitisation, asthma, and a modified Th2 response in children exposed to cat allergen: a population-based cross-sectional study. Lancet 2001; 357:752-6.
25. Reefer AJ, Carneiro RM, Custis NJ et al. A role for IL-10-mediated HLA-DR7-restricted T cell-dependent events in development of the modified Th2 response to cat allergen. J Immunol 2004; 172:2763-72.
26. Sakaguchi H, Inoue R, Kaneko H et al. Interaction among human leucocyte antigen-peptide-T cell receptor complexes in cow's milk allergy: the significance of human leucocyte antigen and T cell receptor-complementarity determining region 3 loops. Clin Exp Allergy 2002; 32:762-70.
27. Jeal H, Draper A, Jones M et al. HLA associations with occupational sensitization to rat lipocalin allergens: a model for other animal allergies? J Allergy Clin Immunol 2003; 111:795-9.
28. Cavaggioni A, Mucignat-Caretta C. Major urinary proteins, alpha(2U)-globulins and aphrodisin. Biochim Biophys Acta 2000; 1482:218-28.
29. Young RP, Dekker JW, Wordsworth BP et al. HLA-DR and HLA-DP genotypes and immunoglobulin E responses to common major allergens. Clin Exp Allergy 1994; 24:431-9.
30. Howell WM, Standring P, Warner JA, Warner JO. HLA class II genotype, HLA-DR B cell surface expression and allergen specific IgE production in atopic and non-atopic members of asthmatic family pedigrees. Clin Exp Allergy 1999; 29 (Suppl. 4):35-8.
31. Hermann R, Turpeinen H, Laine AP et al. HLA DR-DQ-encoded genetic determinants of childhood-onset type 1 diabetes in Finland: an analysis of 622 nuclear families. Tissue Antigens 2003; 62:162-9.
32. Tuokko J, Nejentsev S, Luukkainen R, Toivanen A, Ilonen J. HLA haplotype analysis in Finnish patients with rheumatoid arthritis. Arthritis Rheum 2001; 44:315-22.
33. Kim YK, Oh HB, Oh SY, Cho SH, Kim YY, Min KU. HLA-DRB1*07 may have a susceptibility and DRB1*04 a protective effect upon the development of a sensitization to house dust mite Dermatophagoides pteronyssinus. Clin Exp Allergy 2001; 31:110-5.
34. Lympany P, Kemeny DM, Welsh KI, Lee TH. An HLA-associated nonresponsiveness to mellitin: a component of bee venom. J Allergy Clin Immunol 1990; 86:160-70.
35. Reid MJ, Nish WA, Whisman BA et al. HLA-DR4-associated nonresponsiveness to mountain-cedar allergen. J Allergy Clin Immunol 1992; 89:593-8.
36. Cho SH, Kim YK, Oh HB et al. Association of HLA-DRB1(*)07 and DRB1(*)04 to citrus red mite (Panonychus citri) and house dust mite sensitive asthma. Clin Exp Allergy 2000; 30:1568-75.
37. Zeiler T, Mäntyjärvi R, Rautiainen J et al. T cell epitopes of a lipocalin allergen colocalize with the conserved regions of the molecule. J Immunol 1999; 162:1415-22.
38. Jeal H, Draper A, Harris J, Taylor AN, Cullinan P, Jones M. Determination of the T cell epitopes of the lipocalin allergen, Rat n 1. Clin Exp Allergy 2004; 34:1919-25.
39. Counsell CM, Bond JF, Ohman JL Jr., Greenstein JL, Garman RD. Definition of the human T-cell epitopes of Fel d 1, the major allergen of the domestic cat. J Allergy Clin Immunol 1996; 98: 884-94.
40. Marcotte GV, Braun CM, Norman PS et al. Effects of peptide therapy on ex vivo T-cell responses. J Allergy Clin Immunol 1998; 101:506-13.
41. Kinnunen T, Buhot C, Närvänen A et al. The immunodominant epitope of lipocalin allergen Bos d 2 is suboptimal for human T cells. Eur J Immunol 2003; 33:1717-26.
42. Mark PG, Segal DB, Dallaire ML, Garman RD. Human T and B cell immune responses to Fel d 1 in cat-allergic and non-cat-allergic subjects. Clin Exp Allergy 1996; 26:1316-28.
43. Haselden BM, Syrigou E, Jones M et al. Proliferation and release of IL-5 and IFN-gamma by peripheral blood mononuclear cells from cat-allergic asthmatics and rhinitics, non-cat-allergic asthmatics, and normal controls to peptides derived from Fel d 1 chain 1. J Allergy Clin Immunol 2001; 108:349-56.